INFANT Seminar Series: Dr Dhanis Lad to Discuss the STOP AD Randomised Controlled Trial

By |2022-03-09T14:31:21+00:00March 9th, 2022|

Presentation title: Early initiation of short-term emollient use for the prevention of atopic dermatitis in high-risk infants – the STOP AD randomised controlled trial Atopic dermatitis (AD), also known as eczema, is a chronic inflammatory skin condition, characterized by dry, red and itchy skin. AD usually begins in infancy and affects up to one fifth of [...]